GLP-1 is an incretin hormone released from enteroendocrine cells in response to eating that stimulates insulin secretion, slows gastric emptying and promotes satiety 1,3
Injectable peptides (BPC-157, TB-500, etc.): Promising in preclinical research but still experimental
In an experimental study conducted by Noyan-Ashraf and colleagues, Liraglutide upregulated the independent expression of cardioprotective genes, including Akt, PPAR-, Nrf-2, and HO-1, while suppressing the expression of GSK3 and activation of caspase-3 in murine hearts [56]
Can I Take Them Together Safely
Overall, GLP-1 agonists are safe with the most common side effects of nausea, vomiting, diarrhoea and constipation being only mild to moderate in severity in most people